Home > Boards > US Listed > Medical - Equipment > Pressure BioSciences Inc. (PBIO)

Data from Analysis of Cancer Tissue Proteins Generated

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
jedijazz Member Profile
Member Level 
Followed By 1,143
Posts 149,612
Boards Moderated 51
Alias Born 12/07/09
160x600 placeholder
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/14/2019 5:21:10 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/6/2019 12:04:17 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/3/2019 6:31:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2019 11:03:38 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/21/2019 11:43:40 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/21/2019 11:42:55 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/21/2019 11:42:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/21/2019 11:41:09 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/21/2019 11:39:39 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2019 9:49:17 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/15/2019 3:36:19 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/15/2019 3:31:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2019 7:56:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2019 7:54:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2019 7:51:57 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 4:51:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/1/2019 2:42:10 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/16/2019 4:24:00 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 4/1/2019 5:07:03 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 3/20/2019 5:25:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/15/2019 5:28:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/31/2018 6:11:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/28/2018 5:24:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/26/2018 6:12:14 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2018 6:15:13 PM
jedijazz Member Level  Friday, 11/08/19 11:13:38 AM
Re: None
Post # of 11445 
Data from Analysis of Cancer Tissue Proteins Generated from Novel Workflow Could Lead to Improvement in the Clinical Management of Gynecological Cancers

Oct. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced the Company’s patented pressure cycling technology (“PCT”) platform was featured as an integral part of a new, innovative workflow for the analysis of proteins from cancer biopsy samples. This workflow was presented in a plenary session at the Annual Meeting of the International Gynecologic Cancer Society (“IGCS”) on September 21, 2019 in Rio de Janeiro, Brazil. The mission of the IGCS is to improve the care and outcomes for women with gynecologic cancer worldwide through education, training and public awareness. PBIO



ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist